Dr. Meenakshi Davuluri, MD

Dr. Davuluri practices at NewYork-Presbyterian/Weill Cornell Medical Center in New York, New York, part of NewYork-Presbyterian Hospital.

Dr. Davuluri's NPI, 1043605330, was assigned on April 2, 2015. Dr. Davuluri graduated from SUNY Upstate Medical University in 2015. Dr. Davuluri's New York license number on file is 306104.

Dr. Davuluri's primary practice is NewYork-Presbyterian/Weill Cornell Medical Center, at 525 East 68th Street, New York, NY 10065 in New York County. The practice phone is (212) 746-5454.

Dr. Davuluri's primary practice is NewYork-Presbyterian/Weill Cornell Medical Center in New York, New York, part of NewYork-Presbyterian Hospital. Dr. Davuluri is also affiliated with Geisinger Wyoming Valley Medical Center. The medical group on file is Geisinger. Dmand AI also links Dr. Davuluri to 2 more clinical labs and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Davuluri practices, 4 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Davuluri's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Davuluri is board certified in urology by the American Board of Urology. Dr. Davuluri has a license on file in New York.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney removal surgery, kidney stone disease and pelvic prolapse among the conditions Dr. Davuluri treats.

CMS data shows 617 Medicare services from Dr. Davuluri across 9 procedure codes in 2024, for 281 Medicare patients. Medicare paid $53,841 for them.

CMS counts 281 Medicare patients who saw Dr. Davuluri in 2024. The largest group is 65 to 74, with 117 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 32% are also on Medicaid. Their average risk score is 1.65, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Davuluri's median patient age at 68, with 58% women.

In 2024, Dr. Davuluri wrote 1,015 Medicare Part D claims for 309 patients. 78% of them were for generic drugs. CMS names the drug for 923 of them, across 20 drugs with 11 or more claims each, at $152,074 in total drug cost. In 2023, CMS named 662 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Davuluri for performance year 2024, reported as part of a group.

Dmand AI links 15 papers to Dr. Davuluri, published from 2018 to 2025. 2020 was the busiest year, with 2. The most frequent topics are Prostatic Neoplasms, Neoplasm Grading and Prostatectomy. Dr. Davuluri has published most often in Urol Pract. Dr. Davuluri's most frequent co-authors are Jim C. Hu, MD, MPH, Michael S. Tzeng, MD and Kara L. Watts, MD.

CMS Open Payments shows 34 general payments to Dr. Davuluri from 5 drug and device companies from 2022 to 2025. Travel and lodging make up the largest share, 72% of the total. Boston Scientific Corporation paid the most, $1,815.

Dr. Davuluri graduated from SUNY Upstate Medical University in 2015.

Dr. Davuluri is in network with 17 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.